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Around the year 1990, it was discovered that src-homol- 
ogy 2 (SH2) domains could bind to phosphotyrosine 
(Anderson et al., 1990; Margolis et al., 1990; Mayer and 
Hanafusa, 1990; Moran et al., 1990). A number of pro- 
teins implicated in protein-tyrosine kinase signaling 
pathways were known to contain SH2 domains, and 
this discovery revealed how these proteins could form 
multimeric signaling complexes in response to activa- 
tion of growth factor receptor family protein-Tyr kinases. 
However, this discovery also raised the question of how 
distinct growth factor receptors recruited different sub- 
sets of SH2-containing signaling proteins. 
At about the same time, we had noticed that a tyrosine 
phosphorylation site in polyoma middle t (Tyr-315: Tyr- 
Met-Pro-Met) that was involved in binding to the p85 
regulatory subunit of phosphoinositide 3-kinase (PI3K) 
shared a short sequence motif with two sites in the 
PDGF receptor (Tyr-740: Tyr-Met-Asp-Met and Tyr-751 :
Tyr-VaI-Pro-Met) that had also been recently implicated 
in binding PI3K (Cantley et al., 1991). Also of importance 
was the discovery that other SH2-containing proteins 
appeared to bind at distinct sites on this protein, raising 
the possibility that the SH2 domains of p85 not only 
bound phosphotyrosine, but also recognized a unique 
sequence context immediately C-terminal of the phos- 
photyrosine to insure that PI3K is recruited to only a 
subset of tyrosine-phosphorylated sites. The implication 
was that other SH2 domains might select for distinct 
motifs, thereby providing a zip code for insuring selectiv- 
ity in SH2 domain-mediated recruitment of downstream 
signaling proteins. 
The idea of a unique sequence motif zip code for 
designating binding to each SH2 domain was attractive, 
but to tease out the rules for this selection and identify 
the optimal motif for every SH2 domain was a daunting 
task. With existing technology, it would have required 
synthesis of millions or even billions of individual phos- 
phopeptides and performing binding experiments one 
at a time to be certain of the optimal motif. In 1990, the 
synthesis of phosphopeptides was novel and expensive, 
and large-scale arraying of peptides had not been devel- 
oped. We were extremely lucky to work with Steven 
Shoelson (Harvard Medical School) and Michael Berne 
(Tufts University), two experts in synthesizing phos- 
photyrosine-containing peptides and peptide mixture 
libraries. 
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We realized that although it was expensive to make 
and purify individual phosphopeptides, it was relatively 
cheap to make mixtures of phosphopeptides by adding 
an isokinetic mixture of all 20 amino acids at each round 
of synthesis using a commercial peptide synthesizer. 
The price of making such a library was only slightly more 
than making a single peptide. The question was whether 
a given SH2 domain could selectively extract, from a 
degenerate mixture of phosphotyrosine-containing pep- 
tides, sufficient quantities of high-affinity peptides to 
allow identification. To test this idea, we first synthesized 
a small mixture of phospho-Tyr peptides based on the 
sequence around Tyr-315 of polyoma middle t, but with 
all 20 amino acids rather than just Met at the +3 position 
(e.g., phosphoTyr-Met-Pro-Xxx). This mixture was passed 
over a column containing the N-terminal SH2 domain of 
the p85 subunit of PI3K. The peptide mixture that was 
retained on the column was added directly to an Edman 
sequencer, rather than being separated first into individ- 
ual pure peptides. We reasoned that since all peptides 
in the mixture were the same length and had phospho- 
tyrosine at the same position, the relative abundance of 
the 20 amino acids at the position of degeneracy would 
reveal the relative retention of the 20 peptides. As further 
controls, we compared this sequence with the sequence 
of the starting mixture and with the sequence of the 
flowthrough. To our delight, the sequence of the retained 
peptide mixture revealed almost exclusively Met at 
the +3 position, indicating, as we had suspected, that 
the p85 SH2 domain preferred to bind sites with Met at 
the +3 position. 
This success gave us the courage to apply this ap- 
proach to more degenerate mixtures. We synthesized 
a mixture in which 18 amino acids (omitting Trp and 
Cys) were varied at the three positions C-terminal 
of phosphoTyr (Gly-Asp-Gly-phosphoTyr-Xxx-Xxx-Xxx- 
Ser-Pro-Leu-Leu-Leu) and repeated the same experi- 
ment with this "library." Again, rather than attempt to 
separate the 5832 possible peptides retained and deter- 
mine their relative abundance, we sequenced the mix- 
ture as a batch on an Edman sequencer. The fact that 
all peptides in the library were "oriented" by phosphoty- 
rosine at the fourth residue insured that all the peptides 
would be in phase during sequencing. Thus, during Ed- 
man sequencing of the mixture, cycle 5 from the Edman 
sequencer was the phosphoTyr +1 position in all pep- 
tides (the first position of degeneracy) and thus would 
likely interact with the same region of the SH2 domain. 
The results once again revealed that the subset of 
peptides that were preferentially retained almost all had 
Met at the +3 position. In addition, we found that pep- 
tides with Met, lie, or Val at the +1 position were prefer- 
entially retained but that there was no enrichment for 
particular amino acids in the +2 position in the subset 
of preferentially retained peptides. These results were 
in good agreement with sites on proteins where p85 
binding was implicated, 
Since we did not compare the affinity of individual 
peptides but rather deduced the commonly selected 
amino acids at specific positions relative to phosphoty- 
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rosine in the retained peptides, the implicit assumption 
was that one could obtain useful information about the 
selectivity of a peptide binding domain by evaluating 
each position of the set of high-affinity peptides individ- 
ually in the background of degeneracy at surrounding 
positions. While this simplifying assumption was likely 
to miss some nearest neighbor effects, the consistency 
of the results with in vivo p85 binding sites argued for the 
value of the approach. Importantly, since the approach 
could be expanded to even higher levels of degeneracy 
(eventually to libraries containing billions of peptides), 
did not require foreknowledge of SH2 domain binding 
partners, and could be performed in one day, we realized 
that it was feasible to determine the binding motifs of 
all SH2 domains in a relatively short time. 
Thanks to many people in the field, we were able to 
quickly obtain a large number of SH2 domain constructs 
and examine their specificity using this approach. The 
results from analyses of over 30 SH2 domains not only 
supported our hypothesis that SH2 domains recognize 
specific sequences surrounding the phosphotyrosine, 
but also showed that this information was useful in pre- 
dicting binding partners for individual SH2 domains 
based on primary sequences of proteins (Songyang et 
al., 1993, 1994). For example, we found that the optimal 
motif for binding to the Src SH2 domain was phospho- 
Tyr-Glu-Glu-Ile, a sequence found on polyoma middle 
T antigen. 
Before the specificities of SH2 domains were investi- 
gated systematically, the in vivo targets of SH2 domain 
proteins had been largely unknown. Even in cases where 
receptor tyrosine kinases were found to bind SH2 do- 
main-containing proteins, the exact binding sites of the 
SH2 domains often remained ambiguous. The SH2 do- 
main specificity information gathered from our oriented 
peptide library studies have since helped many labora- 
tories to map the in vivo binding sites of their favorite 
SH2 domains. In the following years, numerous publica- 
tions reported the identification of specific tyrosine se- 
quences recognized by different SH2 domains. As a 
result, our original and subsequent follow-up studies on 
SH2 domain specificities were among the most fre- 
quently referenced publications in the field in the mid 
1990s. 
The identification of optimal phosphotyrosine pep- 
tides for individual SH2 domains also facilitated under- 
standing of the structural basis for SH2 domain specific- 
ity. At the same time that we were determining the 
specificity of SH2 domains, John Kuriyan's laboratory 
published the structure of the Src SH2 domain bound 
to a peptide from the C-terminal tail of c-Src containing 
phosphoTyr-527 (Waksman et al., 1992). However, it was 
difficult o tell from the structure how the specificity of 
SH2 domains was determined, since the peptide was 
of low affinity and revealed minimal contact outside the 
phosphoTyr binding pocket. In the meantime, Stephen 
Harrison's laboratory was crystallizing the SH2 domain 
of the src family member Lck. Both groups were excited 
about our findings and went on to cocrystalize these 
two SH2 domains with the high-affinity phosphoTyr-Glu- 
Glu-Ile peptide (Eck et al., 1993; Waksman et al., 1993). 
These crystal structures provided a clear explanation 
for the selection of acidic residues at the +1 and +2 
positions and revealed a hydrophobic pocket for lie at 
the +3 position. 
Based on the cocrystals of the src and Ick SH2 do- 
mains with the phosphoTyr-Glu-Glu-Ile peptide, we 
were then able to model other SH2 domains and rational- 
ize why they bound distinct peptide motifs. These analy- 
ses revealed critical residues in the SH2 domains that 
were likely to be responsible for determining peptide 
binding specificities. More importantly, once such muta- 
tions were generated, the binding specificity of the mu- 
tant SH2 domain could be quickly reevaluated with our 
oriented peptide library approach. For example, in a 
collaboration with Tony Pawson's group, we showed 
that a single mutation of the Src-SH2 domain could 
switch its binding specificity to resemble that of Sem5/ 
Grb-2 (Marengere et al., 1994). As a result, the mutant 
Src SH2 domain could replace that of SEM-5 in a physio- 
logical setting. 
Looking back, it may be possible to reclassify the 
global approach of determining the binding specifities 
of all SH2 domain as one of the prototypic proteomic 
studies, (although the word proteomic had yet to be 
coined). Incorporating the oriented peptide library data 
and structural modeling, coupled with the then rapidly 
expanding databases, we were able to predict a number 
of potential in vivo targets of SH2 domains. This work 
also paved way for oriented peptide analyses of protein 
kinase specificities and other protein-protein i teraction 
modules such as PTB, PDZ, 14-3-3, and FHA domains 
(Durocher et al., 2000; Songyang et al., 1995b, 1996, 
1997; Yaffe et al., 1997). The quantitative amino acid 
selectivity data produced by these approaches form the 
matrices that are the basis of the Scansite program 
(Yaffe et al., 2001). This program searches protein se- 
quences for a key residue (e.g., Tyr) that is required for 
binding to a domain of interest and then scores the 
immediately surrounding sequence on the basis of how 
strongly the observed amino acid is selected at the same 
position (in relation to the key residue) in the oriented 
peptide library experiment. Unlike traditional pattern 
search algorithms such as ScanProsite, each of the 
matched sequences is given an absolute score and a 
percentile score compared to all other sites in all pro- 
teins in the public database. In the case of SH2 domains, 
because the specificities of protein tyrosine kinases 
have also been examined by peptide libraries (Songyang 
et al., 1995a), it is now possible to predict not only 
whether a Tyr residue in a protein is likely to bind an 
SH2 domain but also whether the Tyr is likely to be 
phosphorylated by any of the protein-Tyr kinases that 
have been evaluated. (Yaffe et al., 2001). These candi- 
date targets ultimately can be evaluated by mutation of 
the predicted tyrosine residues. 
Perspective 
New technologies and improved high-throughput meth- 
ods mean that improvements of this "10 year old" tech- 
nique are likely to blossom in the future. Traditional 
mass-spec approaches, which lack the quantification 
of the Edman approach and the ability to extract consen- 
sus information from simultaneous equencing of bil- 
lions of peptides, have not been very useful in deconvo- 
luting results from soluble peptide library experiments. 
However, improvements in sensitivity, speed, quantita- 
tion, and software may solve this problem. In addition, 
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or iented pept ide l ibraries can be spotted on arrays to 
el iminate the need for pept ide sequencing (Z.S., unpub-  
l ished data). The array approach could also be taken 
one step further by printing all the possible pept ide 
motifs in the genome as arrays. All of  these methods  
are made more powerful  because of the complete  se- 
quencing of the human genome and other genomes.  
Database predict ions can be narrowed by evaluat ing 
the conservat ion of moti fs  through evolut ion.  Ult imately, 
this approach may a l low us to "read" the funct ion of 
motifs and domains  in proteins from linear sequences 
in a fashion analogous to decipher ing words  and para- 
graphs in ancient  and forgotten scripts. 
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